Bausch+Lomb IPO Presentation Deck

Bausch+Lomb at a glance -$3.8B FY21 Revenue BAUSCH+ LOMB 9 consecutive quarters organic growth (non-GAAP) pre-Covid ¹,3 Fully integrated eye care company 1. Organic growth during pre-COVID period (Q4 2017 to Q4 2019) 2. Source: Third party market research, 2019 and management estimates 3. See Slide 2 and Appendix for further non-GAAP information. ~$50B addressable market driven by megatrends² 80+% world population has access to B+L products ii ~100 countries and -12,500 employees PO 168 years of success as a leading eye health brand

View entire presentation